Literature DB >> 17224546

Trimethylaminuria (fish-odor syndrome): a case report.

Gehan Arseculeratne1, Alvin K C Wong, David R Goudie, James Ferguson.   

Abstract

BACKGROUND: Trimethylaminuria (fish-odor syndrome) is a rare metabolic disorder characterized by a body malodor similar to that of decaying fish. The condition results from mutations affecting the flavin-containing monooxygenase 3 (FMO3) gene. Affected individuals may exhibit a variety of psychosocial phenomena. A high index of suspicion for this disorder needs to be maintained when treating individuals presenting with a history of real or perceived body odor. Observation We evaluated a 41-year-old man who presented with a long medical history of a fishy body odor. Results from biochemical investigations confirmed a diagnosis of primary trimethylaminuria, and results of molecular genetic studies revealed homozygosity for a mutation on exon 4 of the FMO3 gene, FMO3/P153L (c.458C --> T). The patient found that information he subsequently obtained about his condition on the Internet and discussion with friends and family members to be the most useful therapeutic approach.
CONCLUSIONS: Trimethylaminuria is a rare metabolic disorder. Psychological accompaniments are recognized as major sources of distress to affected individuals. We discuss the features of this syndrome and highlight the importance of counseling and support in the treatment of such patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224546     DOI: 10.1001/archderm.143.1.81

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Fish odour syndrome.

Authors:  Min Li; Ahmad Al-Sarraf; Graham Sinclair; Jiri Frohlich
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

Review 2.  A review of trimethylaminuria: (fish odor syndrome).

Authors:  Jeffrey Messenger; Shane Clark; Susan Massick; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

Review 3.  Microbiota and Malodor-Etiology and Management.

Authors:  Izabella Mogilnicka; Pawel Bogucki; Marcin Ufnal
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 4.  Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.

Authors:  Ian Steinke; Nila Ghanei; Manoj Govindarajulu; Sieun Yoo; Juming Zhong; Rajesh H Amin
Journal:  Front Physiol       Date:  2020-10-29       Impact factor: 4.566

5.  Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.

Authors:  Xin Wang; Xueqi Li; Yumei Dong
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.